Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSONG.L Regulatory News (SONG)

  • There is currently no data for SONG

Kepler Trust Intelligence: New Research

24 Feb 2022 07:00

RNS Number : 6126C
Hipgnosis Songs Fund Limited
24 February 2022
 

Hipgnosis Songs: New Research

24/02/2022

SONG has continued to deliver, yet now trades at an attractive discount...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEASADADXAEFA
Date   Source Headline
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration
16th May 20237:00 amRNSCorrection of Director/PDMR Shareholding
15th May 20234:32 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSDirectorate Change
16th Mar 20237:00 amRNSDividend Declaration
10th Mar 20235:00 pmRNSDirector/PDMR Shareholding
10th Mar 20234:50 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSTotal Voting Rights
23rd Dec 202211:53 amRNSPublication of Factsheet
13th Dec 20224:03 pmRNSHoldings in Company-Notification of Major Holdings
8th Dec 20227:01 amRNSDividend Declaration
8th Dec 20227:00 amRNSHalf-year Report
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 202210:05 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSNotice: Half Year Results and Capital Markets Day
24th Nov 20226:06 pmRNSHolding(s) in Company
18th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20223:29 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:01 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:35 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20223:16 pmRNSReplacement Transaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSShare Repurchase Programme
10th Oct 20224:41 pmRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSHipgnosis Songs Fund announces interest rate hedge
3rd Oct 20227:00 amRNSHipgnosis Songs Fund announces debt refinancing
21st Sep 20222:59 pmRNSResult of Fourth AGM
21st Sep 20227:00 amRNSDividend Declaration
12th Sep 20224:42 pmRNSRevised Voting by Proxy Deadline
2nd Sep 20224:44 pmRNSHolding(s) in Company
8th Aug 20224:12 pmRNSHolding(s) in Company
3rd Aug 20227:00 amRNSNotice of Annual General Meeting
14th Jul 20227:01 amRNSNew Administration Agreements - Sacem & peermusic
14th Jul 20227:00 amRNSAnnual Financial Report
13th Jul 20227:00 amRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSImpact of Copyright Royalty Board III Decision
12th May 20227:00 amRNSDividend Declaration
13th Apr 202212:05 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSKepler Trust Intelligence: New Research
8th Feb 20227:00 amRNSDividend Declaration
16th Dec 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.